Appili Therapeutics – Press Release Correction [Yahoo! Finance]
Aditxt, Inc. (ADTX)
Company Research
Source: Yahoo! Finance
The Initial Press Release, incorrectly stated that under the terms of the proposed arrangement with Aditxt, Inc. (the “Arrangement”), for each Class A common share of the Company (“Appili Shares”), shareholders will receive (i) US$ 0.467 in cash and (ii) 0.0000686251 of a share of Aditxt common stock (“Aditxt Shares”) (representing a value of approximately US$0.00013 per Appili Share based on the closing price of the Aditxt Shares on October 3, 2024). The reference to US$ 0.467 of cash consideration in the Initial Press Release was in error and such cash amount for each Appili Share should read US$ 0.0467. This press release should be read in conjunction with the Initial Press Release and is subject to the forward looking statement disclaimer set out in the Initial Press Release. These corrections do not change any other information reported in the Initial Press Release. Media Contact Jenna McNeil, Communications Manager Appili Therapeutics E: JMcNeil@AppiliTherapeutics.com
Show less
Read more
Impact Snapshot
Event Time:
ADTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADTX alerts
High impacting Aditxt, Inc. news events
Weekly update
A roundup of the hottest topics
ADTX
News
- Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc. [Yahoo! Finance]Yahoo! Finance
- Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 [Yahoo! Finance]Yahoo! Finance
- Evofem Biosciences Announces Financial Results for the Third Quarter of 2024PR Newswire
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Canadian Business Journal (Canada)]Canadian Business Journal
- Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025 [Yahoo! Finance]Yahoo! Finance
ADTX
Sec Filings
- 11/21/24 - Form 8-K/A
- 11/21/24 - Form 8-K/A
- 11/19/24 - Form 8-K
- ADTX's page on the SEC website